Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AFSSAPS loses patience with implants firm:

This article was originally published in Clinica

Executive Summary

The French healthcare products safety agency, AFSSAPS, has issued a decision banning the further sale and use of a series of medical implantables manufactured by French company, Proconcept, for orthopaedic surgery. The CE marking certificates had expired on the products in February, a fact drawn to the attention of the agency by Proconcept's notified body, TUV Rheinland Product Safety (Germany). The French national society for certification and registration had also mentioned the expired certificate to the French authorities. Despite a series of warnings, the company has not responded to the French authorities. Therefore, the distribution, export and use of the LIFEC lumbar cage, the CIFEC cervical cage, the SRE/SEO lumbar screw systems and the Canaletto carpian canal protectors are banned for all products that were manufactured between February 16 and June 9 2005, bearing the label reference 0197 TUV Rheinland notified body number.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel